Home / Transcripts / Research Solutions, Inc. (RSSS) · September 9, 2026

Research Solutions, Inc. (RSSS) Earnings Call Transcript

September 9, 2026

NASDAQ US Information Technology IT Services earnings 34 min

Earnings Call Speaker Segments

John Beisler executive
#1

Thanks, operator. Good afternoon, everybody, and thanks for joining us for Research Solutions' earnings call covering the fourth quarter and the whole of fiscal year 2026. Joining us today are Roy W. Olivier, our Chairman and Chief Executive Officer, Dave Kutil, our Chief Financial Officer, and Josh Nicholson, our Chief Strategy Officer. Once the market shut this afternoon, the company put out a press release with its results for the fourth quarter of full year fiscal 2026. You can find that release on the company's website, researchsolutions.com. Before management delivers their prepared remarks, I want to remind everyone that certain statements made today are forward-looking and are being made under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from what's expressed or implied, owing to a range of factors. We point you to Research Solutions' recent SEC filings for a more detailed discussion of the risks that could affect the company's future operating results and financial condition. Also, on today's call, management will reference certain non-GAAP financial measures that we believe give investors useful information. A reconciliation of those measures to GAAP measures appears in the earnings press release issued this afternoon. Lastly, I want to remind everyone that this call is being recorded and will be available for replay through a link on the company's website. I'd now like to hand the call over to Roy W. Olivier. Roy?

Roy W. Olivier executive
#2

Thanks, John; the past year was eventful in every way for Research Solutions. Our corporate and academic sales groups performed well, achieving year-over-year growth while also making improvements to both our sales process and our sales team. During that year, we replaced close to 50% of the sales staff and increased the number of sales personnel as we head into FY 2027. We kept moving toward a sales process with more structure, which has led to us finalizing bigger deals than was previously the case, lifted our average sales price, or ASP, across both products, and produced 105 net new deployments over the year. Although the new sales teams are performing well and we have strong confidence that this will carry on in FY 2027, the upsell and renewal teams still require attention. We brought in a new leader for that team, made it stronger and larger, and restructured it according to customer size and location; we also brought in a tool to better gauge customer health and to launch automated and manual workflows depending on what those measurements show. As an example, we can start an engagement workflow aimed at a particular group of users who haven't touched the software or haven't used features we know to be high-value. This all began in early FY 2026, and we observed a solid gain in renewal rates during Q4 of FY 2026. We anticipate that this effort will have a favorable effect on net ARR growth as we enter and move through FY 2027. We did announce 14% B2B ARR growth for the year, which increased our high gross margin platform revenue from 39% of total revenue last year to more than 43% this year, and that produced yet another year of positive results for operating income, net income, EBITDA, and cash flow. Beyond higher sales spending, we put some extra investment into product development and software engineering, which assisted us in launching two new key AI products, while also boosting development velocity on our core Scite and Article Galaxy offerings; furthermore, we made a number of internal adjustments to enhance productivity and output, such as using AI to assist with writing and testing code. All of these gains generated a substantial rise in development productivity; in fact, during the third quarter of FY 2025, we were completing roughly 50 software updates each month; by June of 2026, we reached 200, which is a 4x improvement. Above all, we brought out two AI products that broaden the distinctive capability of Scite and Article Galaxy so they can be reached within ChatGPT, Claude, or Copilot; this reflects our aim to, quote, "be where the researchers are working," end quote, and customers have responded well to those products. As we mentioned in our press release, we recorded approximately $800,000 in AI-related bookings during Q4, and we have established a robust pipeline of interest in those products that we believe will close in FY 2027. I believe a great deal of what we accomplished in FY 2027 will position us well to grow the business profitably in FY 2027. I want to hand things off to Dave so he can take you through the specifics of our fiscal fourth quarter and the complete FY 2026 financial results, and after that I'll talk about what we're aiming for in FY 2027, then finish with a few remarks and the outlook for the coming year. Dave?

Dave Kutil executive
#3

Thanks, Roy, and good afternoon to all of you. I'd like to begin by walking through our fourth quarter, and then I'll move on to an overview of fiscal 2026 results. For the fourth quarter of fiscal 2026, total revenue came in at $12.1 million, versus $12.4 million during the same quarter of fiscal 2025, since growth in platform revenue was outweighed by a drop in transaction revenue. Platform subscription revenue reached $5.3 million, up from $5.2 million a year earlier. This improvement came from higher B2B platform ARR, reflecting a combination of new logo generation plus upsells and cross-sales within our current customer base, partly offset by a decline in B2C ARR; during the quarter we added 29 net new platform deployments, which took total deployments to 1,276 at year-end. We closed the quarter with annual recurring revenue of $22.5 million, a 7.8% increase year-over-year, split into roughly $16.2 million of B2B ARR and approximately $6.3 million of normalized ARR tied to Scite B2C subscribers. B2B ARR rose $2 million, or 14.1%, compared with the year ago period, and that figure included AI-related ARR of $800,000, which was up 125% sequentially from the third quarter of fiscal 2026. Definitions and usage of annual recurring revenue and our other non-GAAP terms can be found in today's press release. Transaction revenue for the fourth quarter totaled approximately $6.8 million, versus $7.3 million in the prior year quarter, which works out to a decline of roughly 6.7%. That marks a sizable improvement over the 11% year-over-year decline we reported in the third quarter and aligns with the stabilization trend we talked about on last quarter's call. Total active customers for the quarter stood at 1,323, compared with 1,338 during the same period a year ago. Gross margin for the fourth quarter came to 53%, which is a 200 basis point gain over the fourth quarter of 2025 and a new quarterly record for the company. This rise reflected the continuing revenue mix shift toward our higher margin platforms business, which now accounts for 43% of total revenue. Gross margin in the platform business was 87.3%, versus an all-time high of 88.5% in the prior year quarter, though it remains comfortably inside our target range of mid 80% gross margin. Within our transactions business, gross margin was 26%, compared with 24.1% in the prior quarter. That gain was mostly due to better margins on our copyright content, driven by favorable publisher mix and pricing, partly offset by lower service fee margins. Total operating expenses for the quarter were $5.6 million, versus $5.1 million in the prior year quarter, as higher sales and marketing expenses and upfront investments in AI were partly offset by lower general and administrative costs relative to the fourth quarter of fiscal 2025. Other expense for the quarter was $135,000, compared with income of $1.2 million in the prior year quarter. That prior year result was mostly due to a favorable adjustment to the final earn-out determination for Scite in the fourth quarter of fiscal 2025. Just to remind everyone, by August 2nd we had wrapped up five quarters’ worth of earn-out payments, and there are still three more payments left in fiscal 2027. For the quarter, net income came in at $666,000, which works out to $0.02 per diluted share, versus $2.4 million, or $0.09 per diluted share, in the same quarter a year earlier. Adjusted EBITDA during the quarter reached $1.4 million, compared with $1.6 million in last year’s fourth quarter. Let me now move on to our full year fiscal 2026 results. Fiscal 2026 total revenue came to roughly $48.3 million, down from $49.1 million in fiscal 2025. Platform subscription revenue rose by about 10%, reaching $20.8 million. We ended the year with 1,276 total deployments, which is a net gain of 105 deployments since the close of fiscal 2025, and our average sales price went up 4.7% thanks to the upselling efforts I mentioned earlier. Looking at ARR, we brought in about $2 million of net B2B ARR over the fiscal year, while normalized B2C ARR fell by roughly $380,000 across the full year. Fiscal 2026 transactions revenue was $27.5 million, versus $30.1 million a year earlier, a drop of about 8.7%, since transaction purchases from new customers were more than offset by lower volumes from a small number of large customers and the transactions-related benefits offered within our platform subscriptions. As I said earlier, that year-over-year trend got better as we came out of the fiscal year. Gross margin for fiscal 2026 was 51.9%, which is a 260 basis point improvement over fiscal 2025. That increase mainly stems from our ongoing revenue shift toward the higher-margin platform business, and it produced a 3.6% rise in gross profit dollars to $25.1 million, even with the lower revenue base. Total operating expenses for fiscal 2026 were $21.5 million, compared with $21.7 million a year earlier. Lower general and administrative and stock compensation expense were partly offset by higher sales and marketing expenses and product development costs. Other expense for the year was $724,000, and it was $1.2 million in fiscal 2025. Last year included $1.7 million to reflect the adjustments made to Scite earn-out finalization. Net income for fiscal 2026 was $2.8 million, or $0.08 per diluted share, versus $1.3 million, or $0.04 per diluted share, a year earlier. Adjusted EBITDA for the year was $5.8 million, compared with $5.3 million in fiscal 2025. Moving to cash flow, cash flow from operations for the fourth quarter was about $1.8 million, compared with $2.3 million in the prior year quarter. For the full year, we generated roughly $5.3 million in cash flow from operations, compared with approximately $7 million in fiscal 2025. As we mentioned on last quarter’s call, that year-over-year decline mainly reflects the timing of working capital payments rather than any change in the underlying earnings power of the business or the collectibility of our receivables. Now turning to our balance sheet, cash and cash equivalents as of June 30th, 2026, were $12.6 million, compared with $12.2 million on June 30th, 2025. When the fiscal year closed, our cash balance stood above where it was twelve months earlier, and that held true even after we covered four quarters' worth of Scite earn-out payments — which lines up with what we told you on last year's fourth quarter call. Nothing was drawn on our revolving line of credit. Thanks to a rising cash position and zero debt, the balance sheet we have now gives us room to finish the rest of the Scite earn-out payments in fiscal 2027, and it also lets us stay ready to pursue strategic alternatives. Turning to fiscal 2027, we anticipate that platform subscription growth will continue, retention will improve, and our transactions business will stabilize further. Along with tight control of expenses, we think we are set up to produce yet another year of growth in adjusted EBITDA and robust cash generation. At this point I'll hand things over to Josh, who will discuss our products. Josh?

Josh Nicholson executive
#4

Yes. Thank you, Dave, and good day to all of you. I wasn't on the previous call because my wife and I were celebrating the birth of our daughter. It's honestly among the greatest experiences anyone could have, and I'm glad to be joining all of you again. There are three areas I'd like to address now: the actual effect AI is having on our operations, the products we released in reply, and the reasons we believe we're positioned correctly for this transition. Let's begin with AI's influence on the business, since I realize it remains top of mind for everybody and it's something we hear about constantly. What we can say is that AI has begun altering the way research is consumed, and our own figures show this plainly. From the time we introduced the Article Galaxy and Scite MCP connectors in February, AI agents have completed over 16 million scholarly reads via Scite. Two aspects of those figures are important for your view of Research Solutions. First, by June — 4 months following launch — tool calls originating from AI agents exceeded the volume of queries made through our own Scite Assistant interface. The usage didn't decline; it relocated. The same questions continue to come from researchers; they're just asking them more and more within Claude, ChatGPT, and Copilot rather than in a browser tab, and a growing number of corporate and academic clients are signing licenses for these tools. Our task is to identify what sets us apart, capitalize on it, and position ourselves wherever users are and wherever we are. The Scite and Article Galaxy connectors appear in the official connector directories for all 3 of these platforms: Copilot, ChatGPT, and Claude. Among doc del tools, Article Galaxy stands alone in having a connector that plugs straight into LLMs. Scite ranks among the handful of scientific article search connectors, and it provides functionality that the platforms lack and that competing search tools also lack; it can reveal whether a claim has been backed or refuted by subsequent research, since we've classified more than 1.6 billion citation statements drawn from the literature's full text. It's also able to search within paywalled full text under our publisher agreement. Moving to the second aspect: approximately 43% of what AI agents seek out lies behind a paywall. That represents the distinctive value that AI and Research Solutions are able to provide jointly. An agent locates a paper in Scite, and roughly 4 times out of 10 it's unable to access the full text. Article Galaxy offers a compliant, rights-cleared route to obtain it. Two decades of publisher relationships and rights settlement aren't going to be upended by a language model. Instead, it turns into what the language model requires. Here's the straightforward truth regarding AI: volume from legacy per-article sales is being squeezed, and Dave took you through the transaction figures; yet that same pressure on document delivery is generating appetite for verified search, verification, and rights-cleared access, and that appetite is flowing into our recurring platform business. Now, for my second area, I'd like to discuss what we released. During fiscal 2026, three big initiatives went live. First, the gateway — MCP access to Scite and Article Galaxy, complete with admin controls, purchasing and ordering, plus coverage extending past papers into patents, grants, clinical trials, and drug and device data. Second, the meter — metered billing tied to agent usage, Pro and Teams plans on Scite, and pooled usage throughout an organization, meaning agentic access is now something we charge for instead of handing out for free. These days, about three-quarters of MCP usage originates from paid plans rather than free ones. Self-serve and the API console arrived in August, letting a developer, a pharma data science team, or an agent begin right away. Third, why does this work commercially? MCP is functioning as an expansion engine. Nearly all MCP deals we closed this year were upsells to current Scite customers, and adding agentic access typically doubled the contract. The initial Article Galaxy MCP deals came in as new logos. A substantial pipeline ROI keeps expanding, and the mix is moving toward bigger corporate deals; that's visible in deal size. Average value of new opportunities generated every quarter has almost doubled across the last two years, with the biggest jump in the two quarters following the MCP launch. Retention tells the same story. Adopters of MCP stick around at much higher rates than non-adopters. Fixing retention and executing the AI strategy amount to one and the same effort. Bring customers into agentic access early and they remain. The final element is supply. We introduced a publisher MCP gateway that renders a publisher's content discoverable by AI agents while keeping paywalled full-text safeguarded, and it provides the publisher a clear view of AI demand for their catalog. Roughly 40 publishers are indexed, and the first two gateway agreements are signed. Each publisher joining boosts the value of the corporate product, and each corporate customer boosts the gateway's value to publishers. In closing, research distribution has changed twice — print to online, and now online to AI. Both times, a fresh layer emerged between content and reader, and that layer seized the growth. We constructed the layer this year. It's live, it's metered, and it sits in the base of what we sell. Fiscal 2027 is about scaling it. Over to you, Roy.

Roy W. Olivier executive
#5

Thank you, Josh. I believe Josh and Dave both did an excellent job describing our results and the steps we've taken to set up the future. I'd like to wrap up by addressing several points. To begin, let me share my thinking on FY 2027. Change will remain a constant in our sector as AI adoption becomes widespread. Our vertical market knowledge runs deep in research, a field where total accuracy is mandatory. I see our role as bridging the distance between an LLM's capabilities and what a research-heavy organization needs. The shift is happening in how researchers begin their work and the instruments they rely on each day. What isn't shifting is that this business revolves around rights management and the expenses associated with doing research. Our mission has always been, and will remain, creating tools researchers can rely on right where they work, in a manner that respects copyright and keeps costs down. Handling entitlements, company IP, rights, billing, and reporting, plus providing access to nearly 160 million journal articles from 1,800 publishers and societies — that's what enterprise research demands. Scite's ability to reach behind the paywall, the distinctive Scite badge indicating an article's quality to the researcher viewing it, and the complete business intelligence suite that helps publishers market AI rights to researchers using usage data — all of this dramatically enhances the LLM experience for the enterprise and the publisher alike. Combine that with our multi-year relationships with more than 1,000 enterprises globally, and we feel confident in our position to participate in AI's growth story moving forward. So what does this mean for FY 2027 results? We don't provide guidance, but I anticipate robust corporate and academic B2B sales in FY 2027, driven by our bigger, more seasoned sales teams and fresh AI offerings. We've observed, and anticipate continuing to observe, better renewals and upsells thanks to a larger, more dedicated team, superior tools that track leading indicators sooner in the ownership cycle, and AI tools that, once deployed, directly boost renewal rates. As our press release noted and as mentioned earlier, we've experienced a significant jump in AI-related product sales and enter FY 2027 with a robust pipeline. I genuinely believe it will be a powerful year on that front. For B2C, I anticipate conditions will stay difficult as intensifying competition pursues the same individual researcher. I do believe our distinctive value applies here too, though in this segment we mostly serve academic researchers who are extremely price-conscious. Where we lose customers to, quote, "try something else," end quote, we win them back through stronger retention and larger monthly payments via MCP with whichever LLM they prefer. Our ASP lifetime value and renewal rates in this segment are climbing. What we'd need to figure out is how to generate meaningful expansion that makes sense given an acceptable cost of acquiring customers. Put simply, my view is that this year will be flat for the business. I do anticipate ongoing pressure when it comes to transactions, or doc del sales, which should produce a decline in the low single digits compared with a year earlier, given that this is a 5-year period being measured against its 5-year CAGR of roughly 1% growth. This remains a significant business, and it will stay that way as the AI era develops. Customers rely on our tools to locate and obtain what they require efficiently and in a manner that respects copyright. None of that is going to shift. Although I can't give you a top-line growth figure, what I can tell you is that my expectation is that all of this will yield better EBITDA and cash flows in FY 2027; we hold close to $13 million in cash, carry no debt, and are producing cash. We keep examining acquisitions that could help speed up growth and bring in distinctive or strategic capabilities, but nothing is set up for the near term. We are aware that our stock price sits well under what we believe it ought to be, and we're assessing every option for boosting shareholder value, whether that's stock buybacks or other methods of deploying the cash to affect that directly; having said that, I'll hand the call back to the operator now for Q&A. Operator?

Jacob Stephan analyst
#6

Hello, folks. Thanks for fielding the questions, and thanks for all the detail too. That AI-related ARR figure — this is the first occasion your team has separated it out. What portion of it is truly new customer spending rather than, say, re-pricing and re-bundling of already-existing subscriptions when they renew? For a second part, could you share thoughts on attach rate alongside FY 2026 renewals?

Roy W. Olivier executive
#7

That figure represents net ARR growth from AI-related offerings, which might come as an upsell or might come as a brand-new sale. I doubt we ran those numbers, and we definitely haven't made them public. An AI-related revenue figure is something we'll share moving forward, though breaking it into upsell versus new is probably not something we'll do. Possibly we could, but I'd need to think that over. I believe we mentioned this, but that stands against roughly nothing 12 months back. The key takeaway is that the MCP, the AI offerings, are beginning to build momentum, since that $800,000 figure comes from a net ARR growth total for the year of, I believe, $1.8 million or $1.9 million. Dave, set me straight if I've got that wrong.

Dave Kutil executive
#8

That's right. Yes.

Jacob Stephan analyst
#9

All right. Understood. Perhaps you might say a few words about pricing. A lot of the industry appears to be moving in the direction of a usage-based model. What approach are you taking on pricing? Does it lean more toward a per-seat basis? Is there a usage element involved? Any detail on that would be useful.

Roy W. Olivier executive
#10

We do operate certain pricing models built around usage, yet usually the price presented to the customer is, when it is not seats, an enterprise one, though it includes caps for usage. Beyond that, additional usage must be purchased.

Jacob Stephan analyst
#11

All right. That's pretty much the same way Anthropic and OpenAI operate right now too.

Roy W. Olivier executive
#12

Correct.

Jacob Stephan analyst
#13

Alright, perhaps just one final thing from my side, regarding Scite MCP and Article Galaxy MCP. Suppose a researcher obtains your information or data through one of those two — what would stop them, I suppose, from having to pay for either Scite or Article Galaxy? Is the MCP essentially a pull-through mechanism that you folks are employing to generate transaction orders, or does some sort of intermediary sit in between?

Roy W. Olivier executive
#14

As things stand, running MCP requires you to hold the matching product. That means an AG license is needed in order to run MCP for AG. A Scite license is needed in order to run MCP for Scite; that said, we're trying out certain new models under which that wouldn't have to be the case. When it comes to the AG side, separating those two is genuinely difficult; on the Scite side, separating those two would be simpler, and we're examining that.

Jacob Stephan analyst
#15

All right. That's quite useful. I'll hand it over now. Appreciate it.

Derek Greenberg analyst
#16

Hello. Picking up where the previous questions left off. Regarding the MCP product, you said it's mainly been sold as an upgrade to existing accounts. I'm curious about how adoption is trending for MCP compared with the legacy offerings. Were you to separate the two, is there erosion in the traditional side relative to MCP, or what's your read on that interplay?

Roy W. Olivier executive
#17

Josh, do you want to field that one?

Josh Nicholson executive
#18

Right. I touched on this briefly, so maybe I'll start with the Scite MCP. When you compare how Assistant and Search are being used versus MCP, users really are shifting toward MCP, so Assistant usage is dropping while MCP is genuinely taking off at a remarkable pace. We're past 18 million AI reads. If you track how that's growing — and we do publish it on the Scite — you can watch it climbing, and just in the past week alone it added 1 million reads. There's a lot happening, and it speaks to the thesis of following where users actually are. Through MCP we're seeing stronger retention and heavier usage. With Article Galaxy, we've taken a more cautious approach to rolling it out. We're weighing various ways to deploy it; we do observe usage among the customer base, and that usage is intriguing, though I'd call it still fairly early. What we're monitoring there is essentially the article purchase, article use, and how that stacks up platform versus MCP. In both instances, everything is essentially plain language. Rather than clicking a button here or there, you're instructing the tool to do this or search for that. I believe that really makes it easier to use both of the product's core differentiators in the places users are beginning to inhabit, including many of our own researchers and developers on the team. More and more of us are everyday users of Claude, not only in software development, but really throughout the org. We ourselves rely on MCPs from some of our tools, like our sales CRM and analytics and similar things.

Derek Greenberg analyst
#19

All right, understood. Could you expand a bit on the gateway products — perhaps the economics on the supply side as well as the demand side — and also how the traction is shaping up there?

Josh Nicholson executive
#20

Yes. It's quite early on that front, but my sense is demand is very large. What I believe publishers are attempting to work out is how their content fits into this AI-driven world. Like I said, our aim is to assist in bringing content into AI, the same way hosting platforms once brought content onto the internet. I think one place we'll begin to see that is through subscription-based access we offer to their subscribers; we capture value for our product, for which we charge. They capture value for their subscribers, plus they receive usage data from it. My view is this will develop as time goes on, and my view is we'll eventually offer a range of different mechanisms and paths for AI licensing. Still, my sense is it remains early, and traction has been limited for anyone in this space; yet demand exists, and I think we're observing solid interest from certain publishers in looking into this alongside us.

Derek Greenberg analyst
#21

All right, understood. Only one more thing from my side. Regarding the pipeline, you said it's been expanding well; however, I wanted to ask — during the prior quarter you gave a figure of more than $1 million for the AI products. Could you share any additional specifics about how that pipeline stands at present?

Roy W. Olivier executive
#22

As of now it's significantly above that level, though a precise figure isn't available to me.

Derek Greenberg analyst
#23

Alright, understood. I appreciate you answering my questions.

Roy W. Olivier executive
#24

Thanks to you, and I want to thank all of you for being with us on today's call. Just a note, we will be taking part tomorrow at the Lake Street conference in New York City. I'm looking forward to talking with you in November, when we'll go over how we did in the first quarter of FY 2027. Enjoy the rest of your day.

Josh Nicholson executive
#25

Thank you.

Operator operator
#26

Thanks. That wraps up the meeting for today. We're grateful for the time you gave us and for taking part. You're welcome to disconnect now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Research Solutions, Inc. transcript - plus 131,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Research Solutions, Inc. earnings transcripts and 131,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.